AIM: The aim of this study was to compare ankle brachial indices (APBI) with pedal waveforms utilizing the continuous wave Doppler in a population with diabetes mellitus. METHODS: A prospective study design was employed to investigate the ABPI in a cohort of 49 people with type 2 diabetes mellitus. ABPI assessment was completed using a portable handheld Doppler and ankle pressures of <0.9 were taken as suggestive of peripheral arterial disease (PAD). Arterial spectral waveforms in each foot were also recorded and compared to the ABPI readings. RESULTS: Inconsistencies were identified between ABPIs and waveform interpretations in the study population. Approximately 35% of subjects had inconsistencies between their ABPI result and waveform interpretation in their right or left foot. CONCLUSIONS: Both ABPIs and Doppler waveforms should be used in the assessment of people with diabetes in order to screen for PAD. This would ensure an accurate assessment of PAD and would allow initiation of appropriate secondary risk factor control measures.
AIM: The aim of this study was to compare ankle brachial indices (APBI) with pedal waveforms utilizing the continuous wave Doppler in a population with diabetes mellitus. METHODS: A prospective study design was employed to investigate the ABPI in a cohort of 49 people with type 2 diabetes mellitus. ABPI assessment was completed using a portable handheld Doppler and ankle pressures of <0.9 were taken as suggestive of peripheral arterial disease (PAD). Arterial spectral waveforms in each foot were also recorded and compared to the ABPI readings. RESULTS: Inconsistencies were identified between ABPIs and waveform interpretations in the study population. Approximately 35% of subjects had inconsistencies between their ABPI result and waveform interpretation in their right or left foot. CONCLUSIONS: Both ABPIs and Doppler waveforms should be used in the assessment of people with diabetes in order to screen for PAD. This would ensure an accurate assessment of PAD and would allow initiation of appropriate secondary risk factor control measures.
Authors: Alfred Gatt; Cynthia Formosa; Kevin Cassar; Kenneth P Camilleri; Clifford De Raffaele; Anabelle Mizzi; Carl Azzopardi; Stephen Mizzi; Owen Falzon; Stefania Cristina; Nachiappan Chockalingam Journal: Int J Vasc Med Date: 2015-01-13
Authors: Jenny B Lin; Evan H Phillips; Ti'Air E Riggins; Gurneet S Sangha; Sreyashi Chakraborty; Janice Y Lee; Roy J Lycke; Clarissa L Hernandez; Arvin H Soepriatna; Bradford R H Thorne; Alexa A Yrineo; Craig J Goergen Journal: Int J Mol Sci Date: 2015-05-18 Impact factor: 5.923
Authors: Alfred Gatt; Owen Falzon; Kevin Cassar; Christian Ellul; Kenneth P Camilleri; Jean Gauci; Stephen Mizzi; Anabelle Mizzi; Cassandra Sturgeon; Liberato Camilleri; Nachiappan Chockalingam; Cynthia Formosa Journal: Int J Endocrinol Date: 2018-03-12 Impact factor: 3.257